iShares MSCI Europe Health Care Sector UCITS ETF (ETR:ESIH)
Germany
· Delayed Price · Currency is EUR 6.35
-0.06 (-1.00%)
May 13, 2025, 5:36 PM CET
-10.06% (1Y)
| Assets | 699.50M |
| Expense Ratio | 0.18% |
| PE Ratio | 21.58 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -9.31% |
| Volume | 48,765 |
| Open | 6.45 |
| Previous Close | 6.41 |
| Day's Range | 6.33 - 6.47 |
| 52-Week Low | 5.69 |
| 52-Week High | 7.83 |
| Beta | 1.09 |
| Holdings | 56 |
| Inception Date | Nov 17, 2020 |
About ESIH
ESIH.L was created on 2020-11-17 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 701.12m in AUM and 43 holdings. The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI Europe Health Care 20/35 Capped Index
Asset Class Equity
Category Health Care
Stock Exchange Deutsche Börse Xetra
Ticker Symbol ESIH
Provider iShares
Index Tracked MSCI Europe Health Care 20/35 Capped Index - EUR
Performance
ESIH had a total return of -9.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.00%.
Top 10 Holdings
77.89% of assets| Name | Symbol | Weight |
|---|---|---|
| Roche Holding AG | ROG | 13.47% |
| Novartis AG | NOVN | 13.24% |
| AstraZeneca PLC | AZN | 12.76% |
| Novo Nordisk A/S | NOVO.B | 12.74% |
| Sanofi | SAN | 7.18% |
| EssilorLuxottica Société anonyme | EL | 4.99% |
| GSK plc | GSK | 4.59% |
| Lonza Group AG | LONN | 3.04% |
| Haleon plc | HLN | 2.93% |
| Alcon Inc. | ALC | 2.93% |